Search Results

Expanding PAD Treatment Options in Office Interventional Suites Using Alternative Access Sites

Insights and tips on using retrograde tibiopedal and radial access in an office setting.

By Daniel Johnston, MD; Mark Rummel, MD; Syed Alam, MD; Krishna M. Jain, MD; and John Munn, MD

An Interview With Daniel A.F. van den Heuvel, MD

Dr. van den Heuvel discusses training of young interventional radiologists, unmet needs in CLTI, developments in venous arterialization, and his special interest in pulmonary artery vascular disease.

Foreign Body Contamination During Interventional Procedures

An underrecognized factor that can cause catastrophic complications.

By John R. Laird, MD; Nick Cavros, MD, FACC; Robert Gallino, MD; Daniel McCormick, DO, FACC, FSCAI; Kelly W. Elliott, RN, MS; and Marsha Holton, CCRN, RCIS, FSICP

Liver-Directed Interventional Oncology: My Top 5 Technical Pearls

Experts provide their top technical tips for cTACE, portal vein embolization, drug-eluting embolic TACE, radiation segmentectomy, parenchyma-sparing Y-90 with flow diversion, challenging ablations, ablation of poorly visualized hepatic tumors, and treatment of parasitized extrahepatic arteries.

By Thierry de Baere, MD; Nadine Abi-Jaoudeh, MD, FSIR, CCRP; Robert J. Lewandowski, MD; Edward Kim, MD, FSIR; Raul N. Uppot, MD; Amanda Smolock, MD, PhD; David S. Wang, MD, FSIR; and Daniel Sze, MD, PhD

Update on SFA Interventions

By Yann Gouëffic, MD, PhD, and Eric A. Secemsky, MD, MSc

Practical IR Approach to Early Stage Hepatocellular Carcinoma

Moderator: Robert J. Lewandowski, MD, FSIR
Panel: Daniel B. Brown, MD, FSIR; Riad Salem, MD, MBA, FSIR; and Fred T. Lee Jr, MD

Immunotherapy and Checkpoint Inhibitors: A Primer for the Interventional Radiologist

The basics of immunology, immunotherapy, and checkpoint inhibitors.

By Joseph P. Erinjeri, MD, PhD, and Daniel T. Sze, MD, PhD

Transarterial Therapy for Patients With Hepatic Malignancy

Transarterial interventions continue to play a key role in managing patients with hepatic malignancy.

By Michael J. Wallace, MD, and Ravi Murthy, MD

Top Tips in Interventional Oncology

Clinical and technical insights into treating hepatocellular carcinoma, cholangiocarcinoma, renal cell carcinoma, lung cancer, bone cancer, and in the palliative care setting.

By Siddharth A. Padia, MD; Theodore Bryan, MD; Rebecca Bennett, MD; Nadine Abi-Jaoudeh, MD, FSIR, CCRP; Raul N. Uppot, MD; Robert Suh, MD; Paul I. Mallinson, MBChB, FRCR, FRCPC; Peter L. Munk, MDCM, FRCPC, FSIR, FFRRCSI (Hon); Miyuki Sone, MD; and Yasuaki Arai, MD, FSIR, FCIRSE

Arterial Oncologic Interventions for Liver-Dominant Metastases

The current state of evidence for arterial interventions for liver metastases.

By W. Brad Butler, BS, and Daniel B. Brown, MD

PIVOTAL Trial Update

With enrollment more than half complete, the PIVOTAL trial aims to answer the question of the best treatment model for patients with small aneurysms.

By Daniel G. Clair, MD, and Kenneth Ouriel, MD